Clinical outcome with concurrent or layered treatment with radium-223 and abiraterone: A retrospective study of real-world experience with patients (pts) with metastatic castration-resistant prostate cancer (mCRPC).

被引：1
|
作者：
George, Daniel J.
Sternberg, Cora N.
Sartor, A. Oliver
Saad, Fred
Tombal, Bertrand F.
Miller, Kurt
Kalinovsky, Jan
Jiao, XiaoLong
Tangirala, Krishna
Higano, Celestia S.
机构：
[1] Duke Canc Inst, Durham, NC USA
[2] Weill Cornell Med, Englander Inst Precis Med, New York, NY USA
[3] Tulane Med Sch, New Orleans, LA USA
[4] Univ Montreal, Ctr Hosp Univ Montreal, Montreal, PQ, Canada
[5] Clin Univ St Luc, Brussels, Belgium
[6] Charite, Dept Urol, Berlin, Germany
[7] Bayer Healthcare Pharmaceut Inc, Basel, Switzerland
[8] Bayer HealthCare Pharmaceut Inc, Whippany, NJ USA
[9] Univ Washington, Seattle, WA 98195 USA
[10] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 07期
关键词：
D O I：
10.1200/JCO.2019.37.7_suppl.253
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
253
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Pain evaluation in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 (Ra-223) in the PARABO observation study
    Palmedo, H.
    Eschmann, S.
    Werner, A.
    Selinski, I.
    Moellers, M-O.
    Kalinovsky, J.
    Benson, A.
    Poeppel, T.
    ANNALS OF ONCOLOGY, 2019, 30 : 336 - 336
  • [22] Radium-223 in Metastatic Castration Resistant Prostate Cancer (mCRPC): a Single Cancer Centre Experience
    Tsoukalas, N.
    Morgui, M. Saigi
    Mills, C.
    Lewington, V.
    Chowdhury, S.
    Rudman, S.
    CLINICAL ONCOLOGY, 2016, 28 (05) : E15 - E15
  • [23] Fracture risk and survival outcomes in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) sequentially treated with abiraterone acetate (AA) and radium-223 (RA223).
    Caffo, Orazio
    Frantellizzi, Viviana
    Tucci, Marcello
    Galli, Luca
    Monari, Fabio
    Baldari, Sergio
    Masini, Cristina
    Bortolus, Roberto
    Facchini, Gaetano
    Alongi, Pierpaolo
    Zichi, Clizia
    Biasco, Elisa
    Fanti, Stefano
    Pignata, Salvatore
    Filice, Angelina
    Borsatti, Eugenio
    Rossetti, Sabrina
    Spada, Massimiliano
    Cortesi, Enrico
    De Vincentis, Giuseppe
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [24] RADIUM-223: TREATING METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
    James, D.
    Hillery, R.
    Freeman, L.
    Kumari, A.
    Kearney, N.
    INTERNAL MEDICINE JOURNAL, 2016, 46 : 30 - 31
  • [25] Selection and monitoring of patients with metastatic castration-resistant prostate cancer for treatment with radium-223
    Rodriguez-Vida, A.
    Torregrosa, M. D.
    Pinto, A.
    Climent, M. A.
    Olmos, D.
    Carles, J.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2018, 20 (06): : 679 - 686
  • [26] When to Initiate Treatment With Radium-223 in Patients With Metastatic Castration-Resistant Prostate Cancer
    Shore, Neal D.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (01) : 26 - 29
  • [27] Selection and monitoring of patients with metastatic castration-resistant prostate cancer for treatment with radium-223
    A. Rodriguez-Vida
    M. D. Torregrosa
    Á. Pinto
    M. Á. Climent
    D. Olmos
    J. Carles
    Clinical and Translational Oncology, 2018, 20 : 679 - 686
  • [28] Four years of clinical experience with Radium-223 for the treatment of castration-resistant prostate cancer
    Alvarez Perez, R. M.
    Delgado Garcia, A.
    Garcia Martinez, S.
    Sanz Viedma, S.
    Palacios Gerona, H.
    Pajares Vinardel, M.
    Jimenez-Hoyuela Garcia, J. M.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2019, 38 (05): : 298 - 304
  • [29] Real-world treatment (Tx) patterns of metastatic castration-resistant prostate cancer (mCRPC) patients (pts) in the US
    Shore, N.
    Laliberte, F.
    Ionescu-Ittu, R.
    Gayle, A.
    Amin, S.
    Yang, L.
    Payne, S.
    Mahendran, M.
    Lejeune, D.
    Yu, L.
    Burgents, J.
    Duh, M. S.
    Ghate, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S534 - S535
  • [30] Metastatic castration resistant prostate cancer patients' experience with Radium-223 treatment in Japan
    Akakura, Koichiro
    Uemura, Hiroji
    Kawakami, Satoru
    Yokomizo, Akira
    Nakamura, Motonobu
    Nishimura, Kazuo
    Komori, Tetsushi
    Ledesma, Dianne Athene
    FUTURE ONCOLOGY, 2024, 20 (12) : 781 - 798
12345